Browsing PubMed İndeksli Yayınlar Koleksiyonu by Publisher "Mary Ann Liebert, Inc"
Now showing items 1-8 of 8
-
Digging deeper into precision/personalized medicine: cracking the sugar code, the third alphabet of life, and sociomateriality of the cell
(Mary Ann Liebert, Inc, 2020)Precision/personalized medicine is a hot topic in health care. Often presented with the motto "the right drug, for the right patient, at the right dose, and the right time," precision medicine is a theory for rational ... -
Does type 2 diabetes mellitus have an impact on postoperative early, mid-term and late-term urinary continence after robot-assisted radical prostatectomy?
(Mary Ann Liebert, Inc, 2019)Objective: We evaluated the effect of diabetes mellitus (DM) on urinary continence after robotic radical prostatectomy (RARP). Patients and Methods: Overall, 99 patients with DM and 213 patients without DM who underwent ... -
Expression of survivin and its splice variants in pediatric acute lymphoblastic leukemia
(Mary Ann Liebert, Inc, 2018)Aims: Survivin is involved in the inhibition of apoptosis and the regulation of cell division. In addition to wild-type survivin (survivin-wt), at least four splice variants with differential functions (Delta Ex3 and 3B ... -
How does infection with human papillomavirus 16 and 18 impact on dna damage and repair in cervical cells and peripheral blood?
(Mary Ann Liebert, Inc, 2018)Human papillomavirus (HPV) infection is one of the most common sexually transmitted diseases worldwide and a prime cause of cervical cancer. The HPV DNA is detected in approximately 80-90% of all cervical cancers, with HPV ... -
It is time to revitalize the Antibiotic Pipeline: Systems ecology can help
(Mary Ann Liebert, Inc, 2020)Antimicrobials have been known for millennia, but innovative antibiotics are currently in short supply. New antimicrobial discoveries are being threatened by planetary scale loss of biodiversity that has important impacts ... -
The level of self-care measures for everyday life in persons who received chemotherapy
(Mary Ann Liebert, Inc, 2017)A self-care measure quantifies patients’ perceived ability for self-care, operationalized in behaviors related to recognizing and managing symptoms, carrying out activities of daily living, and managing changes in the ... -
Panvigilance: integrating biomarkers in clinical trials for systems pharmacovigilance
(Mary Ann Liebert, Inc, 2019)Drug safety and pharmacovigilance are rapidly changing with biomarkers and new technologies such as artificial intelligence. However, we need new ideas and application contexts for integration of biomarkers and emerging ... -
To genotype or phenotype for drug and food safety? Exiting the technology echo chambers
(Mary Ann Liebert, Inc, 2018)Scholars throughout history have argued there is nothing more important than understanding and explaining the world that we live in. Both scientists and social scientists share this motivation. Yet, they employ ...
